Guidance

Varicella vaccine (live): PGD template

Patient group direction (PGD) template to support outbreaks where chickenpox is co-circulating with scarlet fever in non-immune children from 9 months of age and adults.

• From: UK Health Security Agency
• Published: 9 January 2023
• Last updated: 23 December 2024 — See all updates

Applies to England

Documents

Varicella vaccine (live): patient group direction (PGD) template

Ref: UKHSA gateway number GOV-17610

MS Word Document, 230 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This varicella vaccine PGD supports administration of the vaccine to non-immune household contacts of immunosuppressed individuals or identified as being at risk following an outbreak where chickenpox and group A streptococcus (GAS) is co-circulating in nurseries, preschools and other similar settings.

Version 2.0 is valid from 5 January 2025 to 5 January 2027.

Practitioners must not use this patient group direction (PGD) template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, guidelines for the public health management of scarlet fever outbreaks in schools, nurseries and other childcare settings, UK guidelines for the management of contacts of invasive group A streptococcus (iGAS) infection in community settings and the vaccine’s Summary of Product Characteristics.

Published 9 January 2023
Last updated 23 December 2024 + show all updates

1. 23 December 2024

   Added version 2.00 – see page 3 for change history.

2. 9 January 2023

   First published.